AI assistant
Sending…
Revolution Medicines, Inc. — Director's Dealing 2021
Jun 24, 2021
30695_dirs_2021-06-24_deeb9ef8-0599-4b71-9854-b7a3d8bee426.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Revolution Medicines, Inc. (RVMD)
CIK: 0001628171
Period of Report: 2021-06-22
Reporting Person: Borellini Flavia (Director)
More from Revolution Medicines, Inc.
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 13
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 27
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 26